Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HOOK Stock Summary
Top 10 Correlated ETFs
HOOK
In the News
HOOK Financial details
Company Rating
Neutral
Market Cap
75.94M
Income
-81.79M
Revenue
20.13M
Book val./share
0.91
Cash/share
1.18
Dividend
-
Dividend %
-
Employees
151
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-0.93
Forward P/E
-
PEG
1.32
P/S
3.06
P/B
0.68
P/C
0.66
P/FCF
-1.67
Quick Ratio
3.22
Current Ratio
3.44
Debt / Equity
0.07
LT Debt / Equity
0.04
-
-
EPS (TTM)
-0.92
EPS next Y
-
EPS next Q
-
EPS this Y
-13.13%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-14.75%
Revenue last 5Y
11.01%
Revenue Q/Q
7.86%
EPS Q/Q
47.06%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
43.92%
Inst Trans
0.7%
ROA
-42%
ROE
-71%
ROC
-0.65%
Gross Margin
100%
Oper. Margin
-391%
Profit Margin
-338%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.41-2.05
52W High
-
52W Low
-
RSI
54
Rel Volume
0.89
Avg Volume
547.77K
Volume
489.71K
Perf Week
-7.37%
Perf Month
-0.71%
Perf Quarter
70.55%
Perf Half Y
44.33%
-
-
-
-
Beta
1.018
-
-
Volatility
0.02%, 0.04%
Prev Close
-3.77%
Price
0.7794
Change
-1.12%
HOOK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.67 | 0.75 | 0.56 | 0.22 | 0.21 | |
Net income per share | -1.91 | -1.3 | -2.3 | -0.99 | -0.86 | |
Operating cash flow per share | -2.34 | -1.51 | -2.01 | -0.31 | -0.61 | |
Free cash flow per share | -2.45 | -1.6 | -2.39 | -0.38 | -0.65 | |
Cash per share | 6.34 | 5.5 | 2.04 | 1.73 | 1.24 | |
Book value per share | 6.6 | 6 | 2.73 | 1.56 | 0.95 | |
Tangible book value per share | 6.6 | 6 | 2.73 | 1.56 | 0.95 | |
Share holders equity per share | 6.6 | 6 | 2.73 | 1.56 | 0.95 | |
Interest debt per share | 0.64 | 0.43 | 0.35 | 0.11 | 0.07 | |
Market cap | 218.43M | 288.77M | 76.5M | 53.07M | 76.57M | |
Enterprise value | 115.88M | 156.11M | 20.22M | -53.88M | -33.97M | |
P/E ratio | -6.4 | -8.54 | -1.01 | -0.81 | -0.94 | |
Price to sales ratio | 18.29 | 14.75 | 4.15 | 3.72 | 3.8 | |
POCF ratio | -5.23 | -7.34 | -1.16 | -2.65 | -1.33 | |
PFCF ratio | -4.99 | -6.92 | -0.97 | -2.12 | -1.24 | |
P/B Ratio | 1.85 | 1.85 | 0.85 | 0.52 | 0.85 | |
PTB ratio | 1.85 | 1.85 | 0.85 | 0.52 | 0.85 | |
EV to sales | 9.7 | 7.97 | 1.1 | -3.78 | -1.69 | |
Enterprise value over EBITDA | -2.27 | -2.93 | -0.25 | 0.74 | 0.42 | |
EV to operating cash flow | -2.78 | -3.97 | -0.31 | 2.69 | 0.59 | |
EV to free cash flow | -2.65 | -3.74 | -0.26 | 2.15 | 0.55 | |
Earnings yield | -0.16 | -0.12 | -0.99 | -1.23 | -1.07 | |
Free cash flow yield | -0.2 | -0.14 | -1.03 | -0.47 | -0.81 | |
Debt to equity | 0.09 | 0.07 | 0.12 | 0.06 | 0.07 | |
Debt to assets | 0.07 | 0.06 | 0.08 | 0.04 | 0.04 | |
Net debt to EBITDA | 2.01 | 2.49 | 0.69 | 1.46 | 1.36 | |
Current ratio | 8.68 | 8.11 | 3.69 | 4.13 | 3.5 | |
Interest coverage | -58.25 | -67.79 | -90.95 | -106.48 | -267.91 | |
Income quality | 0.97 | 0.89 | 0.87 | 0.31 | 0.71 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.4 | 0.92 | 0.94 | 1.32 | 0.93 | |
Research and developement to revenue | 3.88 | 2.8 | 4.49 | 4.82 | 4.29 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.05 | 0.06 | 0.19 | 0.25 | 0.07 | |
Capex to revenue | -0.17 | -0.12 | -0.68 | -0.35 | -0.21 | |
Capex to depreciation | -1.39 | -0.57 | -2.71 | -1.39 | -1.17 | |
Stock based compensation to revenue | 0.47 | 0.44 | 0.41 | 0.35 | 0.12 | |
Graham number | 16.85 | 13.23 | 11.89 | 5.92 | 4.3 | |
ROIC | -0.3 | -0.24 | -0.77 | -0.65 | -0.85 | |
Return on tangible assets | -0.24 | -0.18 | -0.6 | -0.38 | -0.51 | |
Graham Net | 5.07 | 4.58 | 1.18 | 0.94 | 0.64 | |
Working capital | 113.26M | 150.36M | 74.48M | 111.56M | 105.13M | |
Tangible asset value | 117.9M | 156.12M | 89.59M | 102.52M | 89.86M | |
Net current asset value | 102.17M | 139.81M | 65.68M | 79.26M | 75.64M | |
Invested capital | 0.09 | 0.07 | 0.12 | 0.06 | 0.07 | |
Average receivables | 7.32M | 15.19M | 20.91M | 21.59M | 20.64M | |
Average payables | 2.3M | 4.48M | 8.39M | 7.13M | 8.99M | |
Average inventory | -4.1M | -11.87M | -15.41M | -7.84M | -209.5K | |
Days sales outstanding | 297.3 | 385 | 418.78 | 563.86 | 349.44 | |
Days payables outstanding | 7.44 | 55.02 | 689.25 | 556.11 | 1.28K | |
Days of inventory on hand | -64.55 | -106.81 | -1.2K | -42.46 | 0 | |
Receivables turnover | 1.23 | 0.95 | 0.87 | 0.65 | 1.04 | |
Payables turnover | 49.06 | 6.63 | 0.53 | 0.66 | 0.28 | |
Inventory turnover | -5.65 | -3.42 | -0.3 | -8.6 | 0 | |
ROE | -0.29 | -0.22 | -0.84 | -0.64 | -0.91 | |
Capex per share | -0.11 | -0.09 | -0.38 | -0.08 | -0.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.14 | 0.04 | 0.03 | 0.06 | 0.07 | |
Net income per share | -0.23 | -0.28 | -0.22 | -0.17 | -0.25 | |
Operating cash flow per share | 0.24 | -0.04 | -0.23 | -0.22 | -0.11 | |
Free cash flow per share | 0.23 | -0.04 | -0.24 | -0.25 | -0.12 | |
Cash per share | 2.07 | 1.52 | 1.64 | 0.98 | 1.18 | |
Book value per share | 1.87 | 1.16 | 1.36 | 0.86 | 0.91 | |
Tangible book value per share | 1.87 | 1.16 | 1.36 | 0.86 | 0.91 | |
Share holders equity per share | 1.87 | 1.16 | 1.36 | 0.86 | 0.91 | |
Interest debt per share | 0.12 | 0.08 | 0.05 | 0.03 | 0.07 | |
Market cap | 44.32M | 53.15M | 72.78M | 68M | 80.15M | |
Enterprise value | -62.62M | -51.11M | -58.53M | -35.82M | -30.39M | |
P/E ratio | -0.88 | -0.67 | -1.01 | -0.89 | -0.81 | |
Price to sales ratio | 5.66 | 16.74 | 27.17 | 9.9 | 10.82 | |
POCF ratio | 3.37 | -18.66 | -3.76 | -2.82 | -7.14 | |
PFCF ratio | 3.53 | -17.03 | -3.68 | -2.51 | -6.88 | |
P/B Ratio | 0.43 | 0.64 | 0.65 | 0.72 | 0.89 | |
PTB ratio | 0.43 | 0.64 | 0.65 | 0.72 | 0.89 | |
EV to sales | -8 | -16.09 | -21.85 | -5.22 | -4.1 | |
Enterprise value over EBITDA | 4.61 | 2.26 | 3.43 | 1.58 | 1.8 | |
EV to operating cash flow | -4.77 | 17.95 | 3.03 | 1.49 | 2.71 | |
EV to free cash flow | -4.99 | 16.37 | 2.96 | 1.32 | 2.61 | |
Earnings yield | -0.28 | -0.37 | -0.25 | -0.28 | -0.31 | |
Free cash flow yield | 0.28 | -0.06 | -0.27 | -0.4 | -0.15 | |
Debt to equity | 0.06 | 0.07 | 0.04 | 0.04 | 0.07 | |
Debt to assets | 0.04 | 0.04 | 0.02 | 0.02 | 0.04 | |
Net debt to EBITDA | 7.87 | 4.6 | 7.7 | 4.58 | 6.56 | |
Current ratio | 4.13 | 3.16 | 3.64 | 3.44 | 3.5 | |
Interest coverage | -125.81 | -185.71 | -221.36 | 462.65 | -369.98 | |
Income quality | -1.07 | 0.14 | 1.07 | 1.27 | 0.45 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.49 | 1.54 | 1.66 | 0.72 | 0 | |
Research and developement to revenue | 2.25 | 6.59 | 7.36 | 3.59 | 2.86 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.05 | 0.1 | 0.02 | 0.13 | 0.04 | |
Capex to revenue | -0.08 | -0.09 | -0.17 | -0.44 | -0.06 | |
Capex to depreciation | -0.66 | -0.3 | -0.51 | -6.2 | -0.33 | |
Stock based compensation to revenue | 0.13 | 0.21 | 0.26 | 0.08 | 0.06 | |
Graham number | 3.11 | 2.68 | 2.58 | 1.83 | 2.26 | |
ROIC | -0.12 | -0.25 | -0.18 | -0.22 | -0.18 | |
Return on tangible assets | -0.07 | -0.12 | -0.09 | -0.12 | -0.15 | |
Graham Net | 1.13 | 0.61 | 0.87 | 0.51 | 0.61 | |
Working capital | 111.56M | 95.7M | 121.9M | 98.9M | 105.13M | |
Tangible asset value | 102.52M | 83.48M | 112.33M | 95.05M | 89.86M | |
Net current asset value | 79.26M | 60.3M | 89.36M | 70.51M | 75.64M | |
Invested capital | 0.06 | 0.07 | 0.04 | 0.04 | 0.07 | |
Average receivables | 20.03M | 20.24M | 19.46M | 21.76M | 21.16M | |
Average payables | 6.66M | 6.28M | 9.36M | 10.29M | 10.71M | |
Average inventory | -209.5K | -420K | -210.5K | 0 | 0 | |
Days sales outstanding | 253.08 | 523.2 | 687.38 | 302.1 | 234.16 | |
Days payables outstanding | 546.37 | 691.37 | 1.21K | 1.65K | 880.14 | |
Days of inventory on hand | -41.71 | -41.14 | 0 | 0 | 0 | |
Receivables turnover | 0.36 | 0.17 | 0.13 | 0.3 | 0.38 | |
Payables turnover | 0.16 | 0.13 | 0.07 | 0.05 | 0.1 | |
Inventory turnover | -2.16 | -2.19 | 0 | 0 | 0 | |
ROE | -0.12 | -0.24 | -0.16 | -0.2 | -0.28 | |
Capex per share | -0.01 | 0 | -0.01 | -0.03 | 0 |
HOOK Frequently Asked Questions
What is HOOKIPA Pharma Inc. stock symbol ?
HOOKIPA Pharma Inc. is a US stock , located in New york of Ny and trading under the symbol HOOK
What is HOOKIPA Pharma Inc. stock quote today ?
HOOKIPA Pharma Inc. stock price is $0.7794 today.
Is HOOKIPA Pharma Inc. stock public?
Yes, HOOKIPA Pharma Inc. is a publicly traded company.